These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6055 related articles for article (PubMed ID: 2925280)

  • 21. Synergistic effect of interleukin-2 and a vaccine of irradiated melanoma cells transfected to secrete staphylococcal enterotoxin A.
    Schrayer DP; Kouttab N; Hearing VJ; Wanebo HJ
    Clin Exp Metastasis; 2002; 19(1):43-53. PubMed ID: 11918082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteinuria of B700, a 67 kD albumin-like melanoma-specific antigen.
    Walden TL; Farzaneh NK; Hearing VJ; Gersten DM
    Pigment Cell Res; 1992 Dec; 5(6):387-93. PubMed ID: 1492072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of polyclonal rabbit antisera to mouse melanoma associated antigens using gene gun immunization.
    Surman DR; Irvine KR; Shulman EP; Allweis TM; Rosenberg SA; Restifo NP
    J Immunol Methods; 1998 May; 214(1-2):51-62. PubMed ID: 9692858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the metabolic fate and tissue distribution of B700, an albumin-like melanoma-specific antigen with serum albumin in normal and tumor-bearing mice.
    Farzaneh NK; Walden TL; Hearing VJ; Gersten DM
    Int J Biochem; 1991; 23(12):1385-91. PubMed ID: 1761148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunity to B16 melanoma in mice immunized with IL-2-secreting allogeneic mouse fibroblasts expressing melanoma-associated antigens.
    Kim TS; Russell SJ; Collins MK; Cohen EP
    Int J Cancer; 1992 May; 51(2):283-9. PubMed ID: 1533203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant vaccinia virus vaccine against the human melanoma antigen p97 for use in immunotherapy.
    Estin CD; Stevenson US; Plowman GD; Hu SL; Sridhar P; Hellström I; Brown JP; Hellström KE
    Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1052-6. PubMed ID: 3422478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens.
    Kaplan JM; Yu Q; Piraino ST; Pennington SE; Shankara S; Woodworth LA; Roberts BL
    J Immunol; 1999 Jul; 163(2):699-707. PubMed ID: 10395660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B700, a melanoma-specific antigen, catalyzes metabolism of prostaglandin E2.
    Farzaneh NK; Walden TL; Hearing VJ; Gersten DM
    Int J Cancer; 1990 Jan; 45(1):104-8. PubMed ID: 1688829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization with interleukin-2-secreting allogeneic mouse fibroblasts expressing melanoma-associated antigens prolongs the survival of mice with melanoma.
    Kim TS; Russell SJ; Collins MK; Cohen EP
    Int J Cancer; 1993 Nov; 55(5):865-72. PubMed ID: 8244584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of cell-surface human melanoma-associated antigens identified by rabbit and murine antibodies.
    Bystryn JC; Jacobsen JS; Liu P; Heaney-Kieras J
    Hybridoma; 1982; 1(4):465-72. PubMed ID: 6208141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal antiidiotypic antibodies related to the p97 human melanoma antigen.
    Kahn M; Hellström I; Estin CD; Hellström KE
    Cancer Res; 1989 Jun; 49(12):3157-62. PubMed ID: 2470502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of interleukin-2, natural killer cell activity and anti-melanoma antibodies resulting from immunization of mice with formalinized extracellular antigens (FECA) of murine melanoma.
    Shrayer D; Koness J; Maizel A; Wanebo H
    Melanoma Res; 1992 May; 2(1):47-56. PubMed ID: 1643424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation of metastatic B16 melanoma variants using anti-Met 72 monoclonal antibodies and flow cytometry.
    Xiang J; Kimura AK
    Clin Exp Metastasis; 1987; 5(1):35-42. PubMed ID: 3829495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucocorticoid-induced TNF receptor family related gene activation overcomes tolerance/ignorance to melanoma differentiation antigens and enhances antitumor immunity.
    Ramirez-Montagut T; Chow A; Hirschhorn-Cymerman D; Terwey TH; Kochman AA; Lu S; Miles RC; Sakaguchi S; Houghton AN; van den Brink MR
    J Immunol; 2006 Jun; 176(11):6434-42. PubMed ID: 16709800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Further characterization of a clinically relevant model of melanoma metastasis and an effective vaccine.
    Shrayer D; Bogaars H; Hearing VJ; Maizel A; Wanebo H
    Cancer Immunol Immunother; 1995 May; 40(5):277-82. PubMed ID: 7600558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of hybridoma-exchange antibodies.
    Lloyd KO; Albino A; Houghton A
    Hybridoma; 1982; 1(4):461-3. PubMed ID: 6208140
    [No Abstract]   [Full Text] [Related]  

  • 37. Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal-defined melanoma antigens.
    Saxton RE; Mann BD; Morton DL; Burk MW
    Hybridoma; 1982; 1(4):433-45. PubMed ID: 6208138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and isolation of melanoma-associated antigens with monoclonal antibodies.
    Ross AH; Mitchell KF; Steplewski Z; Koprowski H
    Hybridoma; 1982; 1(4):413-21. PubMed ID: 6765324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
    LaTemple DC; Abrams JT; Zhang SY; Galili U
    Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melanoma: the development of immunoconjugates from a preclinical viewpoint.
    Beaumier PL; Morgan AC; Woodhouse CS; Marchitto KS
    Immunol Ser; 1990; 53():297-316. PubMed ID: 2100562
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 303.